The global ocular pain peribulbar treatment market size was valued at USD 9.35 Million in 2024 and is expected to reach USD 16.09 Million by 2032, at a CAGR of 7.03% during the forecast period
The market growth is largely fueled by the increasing prevalence of ocular disorders and the rising demand for effective pain management solutions in ophthalmic care, leading to higher adoption of Peribulbar treatment in both clinical and hospital settings.
Furthermore, growing awareness among patients and ophthalmologists regarding advanced ocular pain management therapies, combined with technological advancements in drug delivery methods and minimally invasive procedures, is establishing Ocular Pain Peribulbar Treatment as a preferred solution for post-operative and chronic ocular pain. These converging factors are accelerating the uptake of peribulbar treatment solutions, thereby significantly boosting the industry’s growth